Cargando…
Dendritic cell vaccine with Ag85A enhances anti-colorectal carcinoma immunity
Dendritic cells (DCs) are able to trigger T-cell activation and thus have been considered important for vaccine production against cancers. Vaccines containing DCs have been reported to be effective for developing immunity against cancer cells. The interactions between DCs and auxiliary agents are c...
Autores principales: | Zhai, Jingbo, Gao, Wei, Zhao, Leheng, Gao, Zhipeng, Jiang, Xuefeng, Lu, Changlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257656/ https://www.ncbi.nlm.nih.gov/pubmed/30542467 http://dx.doi.org/10.3892/etm.2018.6851 |
Ejemplares similares
-
Ag85A, As an S2 Vaccine Carrier, Reduces the Toxicity of the S2 Vaccine and Enhances the Protective Ability of Mice against Brucella
por: Zhang, Shuai, et al.
Publicado: (2022) -
Fusion of Dendritic Cells Activating Rv2299c Protein Enhances the Protective Immunity of Ag85B-ESAT6 Vaccine Candidate against Tuberculosis
por: Back, Yong Woo, et al.
Publicado: (2020) -
Ensilication Improves the Thermal Stability of the Tuberculosis Antigen Ag85b and an Sbi-Ag85b Vaccine Conjugate
por: Wahid, A. A., et al.
Publicado: (2019) -
Oral S2-Ag85 DNA Vaccine Activated Intestinal Cell dsDNA and RNA Sensors to Promote the Presentation of Intestinal Antigen
por: Sheng, Dang, et al.
Publicado: (2022) -
Ag85A DNA Vaccine Delivery by Nanoparticles: Influence of the Formulation Characteristics on Immune Responses
por: Poecheim, Johanna, et al.
Publicado: (2016)